Henry Schein stock keeps the focus on guidance and operations.
Henry Schein stock remains focused on its health-care distribution model, emphasizing operational execution, margins, and demand across its customer base. The company, a U.S.-listed dental and medical supplies supplier, thrives on recurring purchases and established customer relationships. Its valuation primarily depends on earnings, guidance, and operating commentary, rather than specific product news.
smartIPR Now Available from Henry Schein Orthodontics
Henry Schein Orthodontics (HSO) has announced the availability of the smartIPR advanced interproximal reduction system in the United States, through an exclusive distribution agreement with Eversmile. This system utilizes a vibrating handpiece with non-rotating, lubricated smart DISKS to gently create precise space between teeth, aiming to modernize and simplify IPR procedures. The partnership reinforces HSO's commitment to delivering clinically driven solutions and advancing orthodontic care through innovation.
Henry Schein (HSIC) price target increased by 12.37% to 90.80
The article reports that the price target for Henry Schein (HSIC) has been increased by 12.37% to $90.80. No further details are provided in this brief update.
MCK - Mckesson Corp Latest SEC Filings
This article provides the latest SEC filings and comprehensive financial data for McKesson Corp (MCK). It includes current stock performance metrics, valuation ratios, dividend information, and insider and institutional ownership percentages, alongside various profitability and efficiency ratios.
Henry Schein Inc balances healthcare distribution scale with steady operations
Henry Schein Inc (SCHE) serves as a major distributor of healthcare products and services, primarily for dental, medical, and animal health practitioners. The company differentiates itself through traditional distribution channels combined with practice-management software and value-added services, enhancing customer relationships and generating recurring revenue. Its extensive product portfolio, technology solutions, and comprehensive support services solidify its position in the North American healthcare market.
Should Henry Schein’s (HSIC) GoTu Partnership Reshape Its Efficiency-Focused Dental Staffing Strategy?
Henry Schein recently partnered with GoTu Technology to integrate its workforce platform, aiming to address dental staffing shortages and enhance efficiency. This collaboration aligns with Henry Schein's strategy to shift towards higher-margin technology and services. While the partnership is a long-term initiative, its impact on the company's financial performance and investor sentiment will depend on its execution and how it reinforces or contrasts with other market factors, such as the company's removal from the Russell 1000 Dynamic Index.
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains
Henry Schein Inc. (HSIC) shares rose 2.26% on Thursday, closing at $86.43. Despite this gain, the stock underperformed compared to its competitors, even as the S&P 500 remained largely unchanged and the Dow Jones Industrial Average saw a significant increase. This marks the second consecutive day of gains for the stock.
Dentrix dental practice software from Henry Schein - cloud tools for busy US clinics
Dentrix, Henry Schein's flagship dental practice management software, integrates scheduling, clinical charting, billing, and patient communications into a single platform for US dental offices. The software, which has expanded to include cloud-connected eServices, is crucial for Henry Schein's technology segment and differentiates it from distribution-focused competitors. Its strategic importance lies in deepening customer relationships and contributing to recurring revenue for Henry Schein (NASDAQ: HSIC).
Henry Schein Inc. stock outperforms competitors on strong trading day
Henry Schein Inc. (HSIC) shares rose by 1.20% to $84.52 on Wednesday, outperforming the S&P 500 Index and Dow Jones Industrial Average, which both saw declines. This gain ended a two-day losing streak for the stock.
Henry Schein focuses on dental and medical supplies as a diversified health-care distributor
Henry Schein is a global distributor of health-care products and services, primarily serving dental and medical practices with equipment, consumables, pharmaceuticals, and technology solutions. The company's business model relies on efficient logistics, inventory management, and strong relationships with suppliers and customers. Its dental segment is a key revenue driver, complemented by services to medical offices and specialty markets, aiming to embed itself in customers' daily operations through supply distribution and technology offerings.
Form 144 HENRY SCHEIN INC For: 30 June By Investing.com
This article announces the filing of Form 144 for HENRY SCHEIN INC (HSIC) for the period ending June 30. Form 144 is a notice of the intent to sell restricted securities. The report was published by Investing.com.
Form 144 HENRY SCHEIN INC For: 30 June
This article reports on the filing of Form 144 for Henry Schein Inc. for June 30. It includes standard disclaimers about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that market data may not be real-time or accurate. The content also notes copyright information for Fusion Media.
GoTu and Henry Schein Partner to Address Dental Staffing Shortages
GoTu and Henry Schein have announced a strategic partnership to tackle dental workforce shortages across the United States. This collaboration integrates GoTu’s digital staffing platform with Henry Schein’s distribution network, providing dental practices with enhanced access to temporary and permanent clinical staff. The initiative aims to streamline recruitment and improve operational efficiency for dental offices by connecting them directly to a marketplace for hygienists, assistants, and dentists.
Form 144 HENRY SCHEIN INC For: 30 June By Investing.com
The article reports on a Form 144 filing for HENRY SCHEIN INC for June 30. It includes standard disclaimers about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that market data may not be real-time or accurate. Investors are advised to carefully consider their objectives and seek professional advice before trading.
GoTu, Henry Schein Form Strategic Partnership
GoTu, a leading dental talent marketplace, and Henry Schein, a major provider of healthcare solutions, have formed a strategic partnership. This collaboration aims to address staffing shortages in dental practices by expanding access to GoTu's platform, which connects practices with dental hygienists, assistants, and associate dentists. The partnership integrates GoTu into Henry Schein Dental Recruitment Services, providing flexible staffing solutions to improve practice efficiency and patient care continuity.
HSIC (NASDAQ) Form 144 — Fidelity lists 28,791 shares, $2.43M value
HSIC has filed a Form 144, announcing a proposed resale of 28,791 common shares valued at $2.43 million through Fidelity Brokerage Services LLC. The filing indicates that the shares originated from multiple restricted stock vesting events by the issuer. This information serves to notify the market and investors about potential share supply changes.
GoTu partners with Henry Schein on dental staffing platform
GoTu Technology and Henry Schein Inc. have announced a strategic partnership to enhance dental staffing solutions. This collaboration integrates GoTu's staffing platform with Henry Schein Dental Recruitment Services, aiming to address critical staffing shortages in dental practices nationwide. The partnership expands access to GoTu's technology through Henry Schein's extensive customer network, leveraging GoTu's experience in filling over 500,000 shifts and Henry Schein's significant market presence and financial health.
GoTu partners with Henry Schein on dental staffing platform By Investing.com
GoTu Technology has partnered with Henry Schein Inc. to provide staffing solutions for dental practices, combining GoTu's platform with Henry Schein Dental Recruitment Services. This collaboration aims to address staffing shortages in the dental industry by connecting practices with hygienists, dental assistants, and associate dentists. Henry Schein, with a market capitalization of $9.6 billion, recently reported strong first-quarter 2026 earnings, exceeding Wall Street expectations, and received an upgrade to its stock rating from BTIG.
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
GoTu Technology and Henry Schein, Inc. have formed a strategic partnership to address the ongoing dental workforce shortage in the U.S. This collaboration will integrate GoTu's dental talent marketplace with Henry Schein Dental Recruitment Services, providing dental practices with expanded access to qualified hygienists, assistants, and associate dentists for both temporary and permanent roles. The goal is to enhance practice efficiency, reduce operational stress, and ensure continuity of patient care by leveraging GoTu's technology and Henry Schein's extensive customer network.
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
GoTu Technology and Henry Schein, Inc. have formed a strategic partnership to address staffing shortages in dental practices. This collaboration will integrate GoTu's dental talent marketplace with Henry Schein Dental Recruitment Services, providing expanded access to qualified dental professionals for temporary and permanent positions. The aim is to support practice efficiency, reduce operational strain, and ensure continuity of patient care nationwide.
Henry Schein teams up with GoTu to ease dental staffing gaps
Henry Schein (Nasdaq: HSIC) and GoTu Technology have formed a strategic partnership to address dental staffing shortages nationwide. GoTu's technology-enabled marketplace will integrate into Henry Schein Dental Recruitment Services, providing dental practices with expanded access to temporary and permanent dental hygienists, assistants, and associate dentists. This collaboration aims to enhance practice efficiency and ensure continuity of patient care by leveraging GoTu's platform, which has already filled over 500,000 shifts, and Henry Schein's extensive customer network.
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth With A 3.67% Potential Upside
Henry Schein, Inc. (HSIC), a major player in medical distribution, shows a 3.67% potential upside according to analysts, with an average target price of $88.07. Trading near its 52-week high of $84.95, the company demonstrates financial stability with a forward P/E of 14.36, 6.30% revenue growth, and strong free cash flow of $290.1 million. Its diversified business model across global distribution, specialty products, and technology, combined with positive analyst sentiment, positions it well for long-term growth in the expanding healthcare sector.
Hsbc Holdings PLC Lowers Stock Holdings in Mohawk Industries, Inc. $MHK
HSBC Holdings PLC significantly reduced its stake in Mohawk Industries (NYSE:MHK) by 67.5% in the fourth quarter, selling 57,555 shares and retaining 27,766 shares valued at $3.0 million. Despite this, institutional investors collectively still own 78.98% of the company's stock, though insider selling by CEO Jeffrey S. Lorberbaum and Suzanne L. Helen has been noted. Analysts currently rate Mohawk Industries as a consensus "Hold" with an average target price of $123.33.
Henry Schein focuses on long-term strategy, shares in a defensive health peer group
Henry Schein maintains its position as a mid-cap leader in U.S. healthcare distribution, aligning with defensive healthcare peers due to its long-term strategy. The company focuses on dental, medical, and animal health products for small to mid-sized practitioners, generating over $10 billion in annual revenue. This strategy provides stability and consistent cash flow, distinguishing it from hospital-focused wholesalers while attracting institutional investors seeking defensive sector holdings.
Dentrix Ascend from Henry Schein Inc. - cloud software brings dental teams into one screen
Dentrix Ascend is Henry Schein's cloud-based practice management software for dental clinics, designed to centralize charting, scheduling, billing, and digital imaging into a single browser-based interface. This system aims to streamline dental operations across multiple locations, offering real-time data access and automatic updates, thereby contributing to Henry Schein's strategy of increasing recurring digital revenues. The software targets practices seeking multi-location flexibility and efficient data management, though users note a learning curve when migrating from older systems.
Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains
On Friday, Henry Schein Inc. (HSIC) stock increased by 1.51% to $84.95, marking its fourth consecutive day of gains. However, it still underperformed compared to the broader market, as the S&P 500 Index and Dow Jones Industrial Average both experienced slight declines.
Price to sales forward of Henry Schein, Inc. – NASDAQ:HSIC
This article provides financial data for Henry Schein, Inc. (NASDAQ:HSIC), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or data-only entry from TradingView, offering a snapshot of financial metrics for the company.
Henry Schein opens the week with robust sector positioning, shares trade steadily on Nasdaq
Henry Schein begins the week in a strong position among U.S. medical distributors, with its shares trading steadily on Nasdaq. The company reported adjusted EPS of $1.32, surpassing consensus estimates, indicating stable profits in its dental and medical distribution businesses. Analysts generally hold a "hold" stance, noting consistent execution and a positive Earnings ESP.
Price to book forward of Henry Schein, Inc. – NASDAQ:HSIC
This article provides access to the "Price to book forward" financial metric for Henry Schein, Inc. (NASDAQ: HSIC) on TradingView. It appears to be a stub or a landing page within a larger financial data platform. The page contains navigation for various financial tools and market data services.
Henry Schein, Inc. Actuals & Estimates (NASDAQ:HSIC)
This article provides an overview of Henry Schein, Inc. (NASDAQ:HSIC) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, financial actuals, earnings, revenue, and EBITDA, while also covering frequently asked questions about the company's stock, such as dividend policy and employee count. The article concludes with technical analysis ratings for HSIC.
Henry Schein, Inc. Actuals & Estimates (BMV:HSIC)
This article provides an overview of Henry Schein, Inc. (HSIC) stock on the Mexican Stock Exchange, including its current price, analyst forecasts, historical highs and lows, market capitalization, and recent financial performance. It highlights key financial metrics such as earnings, revenue, net income, and EBITDA, and notes that the company does not pay dividends.
Will Strong Q1 Beat and BOLD+1 Acquisitions Shift Henry Schein's (HSIC) Distribution‑Led Narrative?
Henry Schein (HSIC) exceeded Q1 expectations and continues to expand its BOLD+1 plan by acquiring businesses in software, specialty products, and services, moving beyond traditional distribution. This strategy aims to support earnings through higher-margin solutions despite pressure on core distribution margins. The company projects $14.9 billion revenue and $630.1 million earnings by 2029, with a current fair value estimated at $87.21, suggesting a 9% upside.
HSIC Forecast — Price Target — Prediction for 2027
This article provides key financial information and analyst forecasts for Henry Schein, Inc. (HSIC) stock. It includes recent stock performance, price targets, earnings reports, revenue, market capitalization, and dividend policy, along with a general recommendation for thorough research before investing.
HSIC Forecast — Price Target — Prediction for 2027
This article provides a forecast for Henry Schein, Inc. (HSIC) stock, including analyst price targets and ratings. It details the current stock price, historical highs and lows, and financial metrics such as EPS, revenue, market capitalization, EBITDA, and employee count. The report also addresses frequently asked questions about the company's stock performance and upcoming earnings.
Henry Schein Inc. stock outperforms competitors on strong trading day
Henry Schein Inc. (HSIC) stock increased by 1.05%, closing at $83.69 on Thursday, thereby outperforming the broader market. This marks the third consecutive day of gains for the company's stock, despite a mixed trading session for the Dow Jones Industrial Average and the S&P 500.
Notables in Health Care 2021: Stanley Bergman
This article features Stanley Bergman, the chief executive officer of Henry Schein Inc., as one of the "Notables in Health Care 2021" recognized by Crain's New York Business. Further details about his contributions are likely contained in the full article, which is not provided here.
Henry Schein Inc. stock outperforms competitors on strong trading day
Shares of Henry Schein Inc. (HSIC) rallied 3.40% to $82.82 on Wednesday, outperforming the mixed stock market where the Dow Jones Industrial Average rose and the S&P 500 Index fell. This marked the second consecutive day of gains for the company's stock.
Henry Schein Inc. stock outperforms competitors on strong trading day
Shares of Henry Schein Inc. (HSIC) increased by 1.82% to $80.10 on Tuesday, despite a challenging trading session for the broader market where both the S&P 500 Index and Dow Jones Industrial Average declined. This rise ended a three-day losing streak for the stock.
Henry Schein Inc. stock underperforms Monday when compared to competitors
Henry Schein Inc. (HSIC) stock declined 1.56% on Monday to $78.67, marking its third consecutive day of losses. This underperformance occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index fell. The stock's movement was in contrast to some overall market performance.
Starmer Steps Down as British PM: Time to Reassess Your UK ETF Exposure?
Keir Starmer's resignation as UK Prime Minister, the seventh in a decade, introduces new uncertainty into the British economy, prompting investors to re-evaluate their UK ETF exposure. Despite political instability and post-Brexit challenges, the UK stock market has shown resilience, with the FTSE 100 climbing significantly. Major institutional researchers maintain cautious optimism, focusing on valuation and monetary policy, anticipating GDP growth and interest rate cuts that could boost the stock market.
Global: Prudential appoints new CEO of Wealth
Prudential has appointed Ms. Donna Cotter as CEO of Wealth, effective June 1, 2026. In this new role, Ms. Cotter will lead a standalone wealth business focused on high-net-worth opportunities across Asia. She brings extensive experience from previous roles at HSBC Retail Banking and Wealth Management and as CEO of Sunlife International.
Henry Schein Stock - Saturday deep dive into the business model
This article provides a deep dive into Henry Schein's business model, focusing on how the dental and medical distributor generates revenue, its position in the healthcare supply chain, and key financial data. It highlights the company's reliance on a dense distribution network, private-label products, and integrated practice management software, serving independent dental and medical practices. The piece also touches on its technology offerings, role as a logistical aggregator, and geographic diversification.
Henry Schein (HSIC) Has a Dental-and-Practice-Workflow Platform Bigger Than a Low-Margin Distributor Label
Henry Schein (HSIC) is often miscategorized as a low-margin distributor, but the company's business model extends much further, encompassing a comprehensive dental-and-practice-workflow platform. This platform integrates distribution, equipment, technical service, software, specialty products, and practice support, particularly within office-based care, with dental services making up 52% of its net sales in 2025. The company's recent Q1 2026 results showed significant growth across its segments, emphasizing its transition towards a higher-value service model that provides deeper customer relationships and improved economics through software, equipment, and value-added services.
Copart (CPRT) Has a Salvage-Auction Network and Insurer Workflow Moat Bigger Than a Used-Car Cycle Trade
Copart (CPRT) operates a comprehensive salvage-auction network deeply embedded in insurer workflows, positioning it as an infrastructure-like business rather than a simple cyclical trade on used-car volumes. Its moat is built on physical yard density, extensive buyer liquidity, and a broad range of services that reinforce its network effect and strong relationships with insurance companies. The company's financial performance demonstrates consistent profitability and ongoing expansion, funded by strong operating cash flow.
Henry Schein Inc (HSIC) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Henry Schein Inc (HSIC), outlining the major individual and institutional holders as of recent updates. It breaks down the proportion of shares held by various shareholder types, such as investment advisors and private equity firms, and provides a history of institutional shareholding over recent quarters. The report also lists the top institutional shareholders and their recent activity, alongside related ETFs holding HSIC stock.
Henry Schein Inc (HSIC) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Henry Schein Inc's (HSIC) dividend and stock split history. It notes that no dividend data is available for the past five years and no stock split data is provided. The article also includes current stock performance metrics for HSIC.
Why Henry Schein’s Dentrix Ascend is quietly reshaping digital dental workflows
Henry Schein's Dentrix Ascend is a cloud-based practice management platform designed to streamline dental workflows by operating entirely in a web browser. It eliminates the need for local servers and offers features like integrated clinical tools, automated business metrics, and online patient management. While it provides anywhere-access, its performance is dependent on a stable internet connection.
Henry Schein Inc. stock outperforms competitors despite losses on the day
Shares of Henry Schein Inc. (HSIC) fell 1.53% to $79.97, underperforming the broader market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. Despite the daily loss, the stock closed outperforming its rivals, but remained 10.44% below its 52-week high.
Why Henry Schein’s Dentrix Ascend has become the quiet backbone of busy dental practices
Henry Schein's Dentrix Ascend is cloud-based practice management software designed to streamline operations for dental practices by moving scheduling, charting, and billing to a web browser. It aims to reduce server management headaches and offers standardized workflows, particularly benefiting multi-location groups. This recurring revenue software is seen as a growth driver for Henry Schein's technology segment.
HSIC (NASDAQ) affiliate proposes Common Stock resales via J.P. Morgan
An affiliate of Henry Schein Inc. (HSIC) has filed a Form 144, indicating proposed resales of Common Stock through J.P. Morgan Securities LLC. The filing shows various grant/transfer dates, including March 1, 2019, March 16, 2026, and May 21, 2026, involving entities like Bergman Family 2010 Trust #2 LLC. While specific quantities per individual sale are not fully detailed in the excerpt, the document outlines the intent for affiliated parties to sell shares.
